SALLY VANWINKLE: Open Payments
NPI 1588083778 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 7 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $87 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| ABBVIE INC. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $14 |
Products named: CAPLYTA, QULIPTA, FANAPT, REXULTI, Ozempic.
Industry payments across IN — which companies pay providers there.
